JPRN-UMIN000015367已完成1 期
TANDEM-IRI-TACE combined with systemic FOLFIRI for colorectal liver metastases after oxaliplatin regimen failure: Phase I dose escalation study - TANDEM-IRI-TACE
Radiology, Nara Medical University0 个研究点目标入组 9 人开始时间: 2014年10月8日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 9
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1 Previous pancreato-biliary surgery or post endoscopic sphincteropapillotomy 2. Serious complications 3. Concomitant malignancy 4. A history of allergy to iodine containing agents or contrast media, irinotecan and 5FU 5. Presence of remarkable AP shunts or AV shunts 6. UGT1A1 6, UGT1A1 28
研究者
相似试验
Unknown
不适用
Comparison of a software-based non-invasive diagnosis against catheter-based invasive methods to find the extent of blood flow reduction due to heart blockages (JENIFFER)CTRI/2022/04/042135SankhyaSutra Labs Ltd10
招募中
不适用
On TRACk: a blended intervention incorporating TRaining, prepAration and Counseling to improve inhaler technique and medication adherence in patients with a chronic lung diseaseAsthma/COPDNL-OMON22618ZonMw360
进行中（未招募）
1 期
Phase II/III randomised study combining nivolumab with TACE treatment for patients with liver cancer.Intermediate stage Hepatocellular CarcinomaMedDRA version: 21.0 Level: LLT Classification code 10019828 Term: Hepatocellular carcinoma non-resectable System Organ Class: 100000004864EUCTR2018-000004-42-GBThe Clatterbridge Cancer Centre NHS Foundation Trust522
尚未招募
3 期
Study of induction chemotherapy in advance stage of cancerCTRI/2017/04/008425TMC Research Administrative Council1,068
进行中（未招募）
1 期
Randomised study to investigate FOLFOXIRI plus Cetuximab or FOLFOXIRI plus bevacizumab as first-line treatment of BRAF-mutated metastatic colorectal cancer (FIRE 4.5)Histologically confirmed, UICC stage IV adenocarcinoma of the colon or rectum with metastases (metastatic colorectal cancer, mCRC), primarily non-resectable or surgery refused by the patientRAS wild-type tumour status (KRAS and NRAS exons 2, 3, 4) (proven in the primary tumour or metastasis)BRAF-mutated (V600E) tumour (proven in the primary tumour or metastasis)MedDRA version: 21.0Level: LLTClassification code 10052362Term: Metastatic colorectal cancerSystem Organ Class: 100000004864EUCTR2015-004849-11-DEniversity Clinic od Munich-Großhadern (represented by the medical management)108